RecruitingNCT04906928

Evaluation of New MRI Sequences Including 3D-FGAPSIR for the Optimization of Inflammatory Spinal Cord Lesions Research

Evaluation of the Performance of a 3D FGAPSIR Sequence by MRI in the Detection and Characterization of Spinal Cord Injuries in Patients With Multiple Sclerosis

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrollment

200 participants

Start Date

Oct 25, 2023

Study Type

OBSERVATIONAL

Conditions

Spinal Cord Injuries

Summary

* verification of inclusion and non-inclusion criteria * information and collection of consent * standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence. * 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Patient over 18 years old
To benefit from a medullary exploration planned by 3T MRI as part of a first evaluation or a reassessment of inflammatory involvement of the nevrax
Express consent to participate in the study
Affiliate or beneficiary of a social security scheme

Exclusion Criteria3

Patient benefiting from a legal protection measure
Pregnant, parturient or breastfeeding woman
Absolute or relative contraindication to MRI

Interventions

DEVICEMRI

* standard imaging protocol prescribed as part of the usual treatment: sagittal T1 and T2 slices after injection of contrast product (Gadolinium), 3D STIR and 3D PSIR sequence. * 3D FGAPSIR sequence at the level of the cervical cord for the duration of the additional sequence is 10 minutes, for a total examination time of 40 minutes (instead of 30 minutes)